124
Views
0
CrossRef citations to date
0
Altmetric
Articles

Barley Grass Juice Attenuates Hydrodynamic Transfection-Induced HCC Initiation in Mice

, , , , , , , , & show all
Pages 750-760 | Received 21 Mar 2022, Accepted 16 Nov 2022, Published online: 10 Dec 2022

References

  • Cruz-Paredes C, López-García Á, Rubaek GH, Hovmand MF, Sørensen P, Kjøller R. Risk assessment of replacing conventional P fertilizers with biomass ash: residual effects on plant yield, nutrition, cadmium accumulation and mycorrhizal status. Sci Total Environ. 2017;575:1168–1176. doi: 10.1016/j.scitotenv.2016.09.194.
  • Obadi M, Sun J, Xu B. Highland barley: chemical composition, bioactive compounds, health effects, and applications. Food Res Int. 2021;140:110065. doi: 10.1016/j.foodres.2020.110065.
  • Farag MA, Xiao J, Abdallah HM. Nutritional value of barley cereal and better opportunities for its processing as a value-added food: a comprehensive review. Crit Rev Food Sci Nutr. 2022;62(4):1092–1104. doi: 10.1080/10408398.2020.1835817.
  • Choi SW, Kim SH, Lee KS, Kang HJ, Lee MJ, Park KI, Lee JH, Park KD, Seo WD. Barley seedling extracts inhibit RANKL-induced differentiation, fusion, and maturation of osteoclasts in the early-to-late stages of osteoclastogenesis. Evid Based Complement Alternat Med. 2017;2017:6072573. doi: 10.1155/2017/6072573.
  • Brezinova Belcredi N, Ehrenbergerova J, Fiedlerova V, Belakova S, Vaculova K. Antioxidant vitamins in barley green biomass. J Agric Food Chem. 2010;58:11755–11761. doi: 10.1021/jf1014389.
  • Cremer L, Herold A, Avram D, Szegli G. A purified green barley extract with modulatory properties upon TNF alpha and ROS released by human specialised cells isolated from RA patients. Roum Arch Microbiol Immunol. 1998;57(3–4):231–42.
  • Yamaura K, Tanaka R, Bi Y, Fukata H, Oishi N, Sato H, Mori C, Ueno K. Protective effect of young green barley leaf (Hordeum vulgare L.) on restraint stress-induced decrease in hippocampal brain-derived neurotrophic factor in mice. Pharmacogn Mag. 2015;11(1):S86–S92. doi: 10.4103/0973-1296.157702.
  • Czerwonka A, Kawka K, Cykier K, Lemieszek MK, Rzeski W. Evaluation of anticancer activity of water and juice extracts of young Hordeum vulgare in human cancer cell lines HT-29 and A549. Ann Agric Environ Med. 2017;24(2):345–11761. doi: 10.26444/aaem/74714.
  • Kawka K, Lemieszek MK, Rzeski W. Chemopreventive properties of young green barley extracts in in vitro model of colon cancer. Ann Agric Environ Med. 2019;26(1):174–11761. doi: 10.26444/aaem/102624.
  • Kubatka P, Kello M, Kajo K, Kruzliak P, Výbohová D, Šmejkal K, Maršík P, Zulli A, Gönciová G, Mojžiš J, et al. Young barley indicates antitumor effects in ­experimental breast cancer in vivo and in vitro. Nutr Cancer. 2016;68(4):611–11761. doi: 10.1080/01635581.2016.1154577.
  • Thatiparthi J, Dodoala S, Koganti B, Kvsrg P. Barley grass juice (Hordeum vulgare L.) inhibits obesity and improves lipid profile in high fat diet-induced rat model. J Ethnopharmacol. 2019;238:111843. doi: 10.1016/j.jep.2019.111843.
  • Ho C, Wang C, Mattu S, Destefanis G, Ladu S, Delogu S, Armbruster J, Fan L, Lee SA, Jiang L, et al. AKT (v-akt murine thymoma viral oncogene homolog 1) and N-Ras (neuroblastoma ras viral oncogene homolog) coactivation in the mouse liver promotes rapid carcinogenesis by way of mTOR (mammalian target of rapamycin complex 1), FOXM1 (forkhead box M1)/SKP2, and c-Myc pathways. Hepatology. 2012;55(3):833–11761. doi: 10.1002/hep.24736.
  • Tward AD, Jones KD, Yant S, Cheung ST, Fan ST, Chen X, Kay MA, Wang R, Bishop JM. Distinct pathways of genomic progression to benign and malignant tumors of the liver. Proc Natl Acad Sci USA. 2007;104(37):11761–14771. doi: 10.1073/pnas.0706578104.
  • Chen X, Calvisi DF. Hydrodynamic transfection for generation of novel mouse models for liver cancer research. Am J Pathol. 2014;184(4):912–11761. doi: 10.1016/j.ajpath.2013.12.002.
  • Loomba R, Lim JK, Patton H, El-Serag HB. AGA clinical practice update on screening and surveillance for hepatocellular carcinoma in patients with nonalcoholic fatty liver disease: expert review. Gastroenterology. 2020;158(6):1822–11761. doi: 10.1053/j.gastro.2019.12.053.
  • Gu Y, Li X, Bi Y, Zheng Y, Wang J, Li X, Huang Z, Chen L, Huang Y, Huang Y, et al. CCL14 is a prognostic biomarker and correlates with immune infiltrates in hepatocellular carcinoma. Aging (Albany NY). 2020;12(1):784–807. doi:10.18632/aging.102656.
  • Krenkel O, Tacke F. Liver macrophages in tissue homeostasis and disease. Nat Rev Immunol. 2017;17(5):306–11761. doi: 10.1038/nri.2017.11.
  • Zhu H, Yu H, Zhou H, Zhu W, Wang X. Nuclear PHGDH promotes neutrophil recruitment to drive liver cancer progression. Bio Rxiv. 2021. doi:10.1101/2021.10.17.464745.
  • Lim SY, Yuzhalin AE, Gordon-Weeks AN, Muschel RJ. Tumor-infiltrating monocytes/macrophages promote tumor invasion and migration by upregulating S100A8 and S100A9 expression in cancer cells. Oncogene. 2016;35(44):5735–11761. doi: 10.1038/onc.2016.107.
  • Afik R, Zigmond E, Vugman M, Klepfish M, Shimshoni E, Pasmanik-Chor M, Shenoy A, Bassat E, Halpern Z, Geiger T, et al. Tumor macrophages are pivotal constructors of tumor collagenous matrix. J Exp Med. 2016;213(11):2315–11761. doi: 10.1084/jem.20151193.
  • Cao X, Zhang Y, Zhou Q, Sun S, He M, Wang X, Ma P, Yang X, Lv L, Zhan L, et al. Establishment of a novel mouse hepatocellular carcinoma model for dynamic monitoring of tumor development by bioluminescence imaging. Front Oncol. 2022;12:794101. doi: 10.3389/fonc.2022.794101.
  • Ma C, Kesarwala AH, Eggert T, Medina-Echeverz J, Kleiner DE, Jin P, Stroncek DF, Terabe M, Kapoor V, ElGindi M, et al. NAFLD causes selective CD4(+) T lymphocyte loss and promotes hepatocarcinogenesis. Nature. 2016;531(7593):253–11761. doi: 10.1038/nature16969.
  • Eggert T, Wolter K, Ji J, Ma C, Yevsa T, Klotz S, Medina-Echeverz J, Longerich T, Forgues M, Reisinger F, et al. Distinct functions of aenescence-associated immune responses in liver tumor surveillance and tumor progression. Cancer Cell. 2016;30(4):533–11761. doi: 10.1016/j.ccell.2016.09.003.
  • Ringelhan M, Pfister D, O'Connor T, Pikarsky E, Heikenwalder M. The immunology of hepatocellular carcinoma. Nat Immunol. 2018;19(3):222–11761. doi: 10.1038/s41590-018-0044-z.
  • Hanahan D, Coussens LM. Accessories to the crime: functions of cells recruited to the tumor microenvironment. Cancer Cell. 2012;21(3):309–11761. doi: 10.1016/j.ccr.2012.02.022.
  • Ma C, Zhang Q, Ye J, Wang F, Zhang Y, Wevers E, Schwartz T, Hunborg P, Varvares MA, Hoft DF, et al. Tumor-infiltrating gammadelta T lymphocytes predict clinical outcome in human breast cancer. J Immunol. 2012;189(10):5029–11761. doi: 10.4049/jimmunol.1201892.
  • Zhu AX, Duda DG, Sahani DV, Jain RK. HCC and angiogenesis: possible targets and future directions. Nat Rev Clin Oncol. 2011;8(5):292–301. doi: 10.1038/nrclinonc.2011.30.
  • Morse MA, Sun W, Kim R, He AR, Abada PB, Mynderse M, Finn RS. The role of angiogenesis in hepatocellular carcinoma. Clin Cancer Res. 2019;25(3):912–11761. doi: 10.1158/1078-0432.CCR-18-1254.
  • Gül N, Babes L, Siegmund K, Korthouwer R, Bögels M, Braster R, Vidarsson G, ten Hagen TLM, Kubes P, van Egmond M, et al. Macrophages eliminate circulating tumor cells after monoclonal antibody therapy. J Clin Invest. 2014;124(2):812–11761. doi: 10.1172/JCI66776.
  • Tian Z, Hou X, Liu W, Han Z, Wei L. Macrophages and hepatocellular carcinoma. Cell Biosci. 2019;9:79. doi: 10.1186/s13578-019-0342-7.
  • Liu N, Wang X, Steer CJ, Song G. MicroRNA-206 promotes the recruitment of CD8(+) T cells by driving M1 polarisation of Kupffer cells. Gut. 2022;71(8):1642–11761. doi: 10.1136/gutjnl-2021-324170.
  • Jenne CN, Kubes P. Immune surveillance by the liver. Nat Immunol. 2013;14(10):996–1006. doi: 10.1038/ni.2691.
  • Lopez BG, Tsai MS, Baratta JL, Longmuir KJ, Robertson RT. Characterization of Kupffer cells in livers of developing mice. Comp Hepatol. 2011;10(1):2. doi: 10.1186/1476-5926-10-2.
  • Davies LC, Jenkins SJ, Allen JE, Taylor PR. Tissue-resident macrophages. Nat Immunol. 2013;14(10):986–995. doi:
  • Fu Y, Liu S, Zeng S, Shen H. From bench to bed: the tumor immune microenvironment and current immunotherapeutic strategies for hepatocellular carcinoma. J Exp Clin Cancer Res. 2019;38(1):396. doi: 10.1186/s13046-019-1396-4.
  • Kurebayashi Y, Ojima H, Tsujikawa H, Kubota N, Maehara J, Abe Y, Kitago M, Shinoda M, Kitagawa Y, Sakamoto M, et al. Landscape of immune microenvironment in hepatocellular carcinoma and its additional impact on histological and molecular classification. Hepatology. 2018;68(3):1025–11761. doi: 10.1002/hep.2990.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.